KBI Biopharma Company Updates | Glassdoor

Company Updates

  • KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities, January 22nd, 2018

    DURHAM, NC - KBI Biopharma, Inc. (KBI) has completed the acquisition of the assets of Elion Labs (Elion), a leading contract services organization in Louisville, CO founded to serve the analytical development and product characterization needs of the biopharmaceutical industry. Elion’s services include analytical method development, qualification and validation, characterization of biologics, and comprehensive data analysis including visualization and interpretation of complex data sets. KBI has aggressively expanded its capabilities in the last 12 months. In addition to expanding its existing Durham, NC and Boulder, CO facilities, the company has added cell therapy development and manufacturing in The Woodlands, TX, integrated the Selexis cell line development technology into its mammalian cell culture development and manufacturing platforms in NC, and completed the acquisition of Alliance Protein Laboratories in San Diego.

Work at KBI Biopharma? Share Your Experiences

KBI Biopharma
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or